I really do not see any short term catalysts moving this to .20 or above outside of a lympro order i dont see amything moving it at all....i think 2016 2017 will be monumental years but i expect near term significant dilution to pay for our acquisitions...elto partner will be 2016 imo no buyout or partner for diagnostics in 2015 imo